D.B. Shin

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Yoon‐Koo Kang, Won Ki Kang, D.B. Shin et al. · Annals of Oncology · 2009 · 777 citations · Full text

Medicine, Oncology, Pharmacology +15

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn et al. · Annals of Oncology · 2020 · 286 citations · Full text

Medicine, Oncology, Surgery +17

Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS)

Min‐Hee Ryu, Eishi Baba, K.H. Lee et al. · Annals of Oncology · 2015 · 49 citations · Full text

Medicine, Oncology, Chemotherapy +14

Randomized phase II study of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) combination chemotherapy for advanced gastric cancer

So-Min Park, Eunmi Nam, Jinny Park et al. · Annals of Oncology · 2007 · 42 citations · Full text

Medicine, Oncology, Pharmacology +14

Randomized Phase Ii Study of Capecitabine and Cisplatin with or Without Sorafenib in Patients with Metastatic Gastric Cancer: Stargate Study

Yoon‐Koo Kang, K.H. Lee, Lin Shen et al. · Annals of Oncology · 2014 · 17 citations

Medicine, Oncology, Pharmacology +16